Saturday, March 17, 2018 7:11:55 AM
Hope. Dead Wrong I am afraid.
The alleged infringement is purely historical. These patents are long since expired. The litigation has no bearing on JnJ or anyone else's freedom to sell the products in question in the market today or in the future. Therefore the litigation could be included or excluded from the sale by agreement of buyer or seller. The potential risk (for that is all it is - potential!) of any liability can be assigned an agreed actuarial value and to be either included in or deducted from the sale price, depending on whether liability for the historical infringement transfers to the buyer or continues to be underwritten by JnJ.
Its really an insurance question, effectively.
Beyond that, the litigation has little or no bearing upon the sale of the Lifescan franchise
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM